Terns Pharmaceuticals, Inc. Share Price
TERNTerns Pharmaceuticals, Inc. Stock Performance
Open $36.48 | Prev. Close $36.89 | Circuit Range N/A |
Day Range $36.38 - $37.83 | Year Range $1.86 - $48.26 | Volume 76,393 |
Average Traded $36.98 |
Terns Pharmaceuticals, Inc. Share Price Chart
About Terns Pharmaceuticals, Inc.
Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in Phase 1 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase IIa clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis (MASH); and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for obesity, as well as TERN-800 series of small-molecule glucose-dependent insulinotropic polypeptide receptor (GIPR) modulators for obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.
Terns Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
21-Jan-26 | $36.48 | $36.66 | +0.00% |
21-Jan-26 | $36.48 | $36.66 | +0.21% |
20-Jan-26 | $35.61 | $36.58 | -0.11% |
16-Jan-26 | $36.87 | $36.62 | -0.99% |
15-Jan-26 | $36.93 | $36.98 | -0.58% |
14-Jan-26 | $34.10 | $37.20 | +7.98% |
13-Jan-26 | $34.08 | $34.45 | +0.97% |
FAQs on Terns Pharmaceuticals, Inc. Share Price
Can I buy Terns Pharmaceuticals, Inc. shares in India?
What is the share price of Terns Pharmaceuticals, Inc.?
What is the 5 year returns of Terns Pharmaceuticals, Inc.?
What are the high & low stock price of Terns Pharmaceuticals, Inc. today?
What is the 52-week high and low of Terns Pharmaceuticals, Inc. stock?